Stanley Druckenmiller Moderna, Inc. Transaction History

Duquesne Family Office LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $21.9 Million - $36 Million	-185,526 Reduced 89.33%	22,154 $2.62 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $24.3 Million - $36.7 Million	207,680 New	207,680 $29.7 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $19.4 Million - $31.7 Million	-85,971 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $30.3 Million - $66.1 Million	-136,429 Reduced 61.34%	85,971 $33.1 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $28.9 Million - $52.3 Million	222,400 New	222,400 $52.3 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Duquesne Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Duquesne Family Office LLC and Stanley Druckenmiller with notifications on news.